Caren van Roekel

289 Discussion 104. Sunakawa Y, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, et al. CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer. Target Oncol. 2017;12(6):787-94. Epub 2017/10/25. 105. van Roekel C, Smits MLJ, Prince JF, Bruijnen RCG, van den Bosch M, Lam M. Quality of life in patients with liver tumors treated with holmium-166 radioembolization. Clin Exp Metastasis. 2020;37(1):95-105. Epub 2019/11/17. 106. Wolstenholme J, Fusco F, Gray AM, Moschandreas J, Virdee PS, Love S, et al. Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer. Int J Cancer. 2019. Epub 2019/12/17. 10